References
- Schweitzer, V G. Ototoxicity of chemotherapeutic agents. Otolaryngol. Clin. North Am. 1993, 26 (5), 759–789. [PUBMED], [INFOTRIEVE], [CSA]
- Brock, P R.; Bellman, S C.; Yeomans, E C.; Pinkerton, C R.; Pritchard, J. Cisplatin ototoxicity in children: a practical grading system. Med. Pediatr. Oncol. 1991, 19 (4), 295–300. [PUBMED], [INFOTRIEVE]
- Ruiz, L.; Gilden, J.; Jaffe, N.; Robertson, R.; Wang, Y M. Auditory function in pediatric osteosarcoma patients treated with multiple doses of cis-diamminedichloroplatinum(II). Cancer Res. 1989, 49 (3), 742–744. [PUBMED], [INFOTRIEVE]
- Schell, M J.; McHaney, V A.; Green, A A.; Kun, L E.; Hayes, F A.; Horowitz, M.; Meyer, W H. Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J. Clin. Oncol. 1989, 7 (6), 754–760. [PUBMED], [INFOTRIEVE]
- Ilveskoski, I.; Saarinen, U M.; Wiklund, T.; Perkkio, M.; Salmi, T T.; Lanning, M.; Makipernaa, A.; Pihko, H. Ototoxicity in children with malignant brain tumors treated with the “8 in 1” chemotherapy protocol. Med. Pediatr. Oncol. 1996, 27 (1), 26–31. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bokemeyer, C.; Berger, C C.; Hartmann, J T.; Kollmannsberger, C.; Schmoll, H J.; Kuczyk, M A.; Kanz, L. Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer. Br. J. Cancer 1998, 77 (8), 1355–1362. [PUBMED], [INFOTRIEVE]
- Reddel, R R.; Kefford, R F.; Grant, J M.; Coates, A S.; Fox, R M.; Tattersall, M H. Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration. Cancer Treat. Rep. 1982, 66 (1), 19–23., [PUBMED], [INFOTRIEVE], [CSA]
- Vermorken, J B.; Kapteijn, T S.; Hart, A A.; Pinedo, H M. Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration. Eur. J. Cancer Clin. Oncol. 1983, 19 (1), 53–58. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Langer, T.; Henze, G.; Beck, J. Basic methods and the developing structures of a late effects surveillance system (LESS) in the long-term follow-up of pediatric cancer patients in Germany. Med. Pediatr. Oncol. 2000, 34 (5), 348–351. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Langer, T.; Stohr, W.; Bielack, S.; Paulussen, M.; Treuner, J.; Beck, J. Late effects surveillance system for sarcoma patients. Pediatr. Blood Cancer 2004, 42, 373–379. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Peters, U.; Preisler-Adams, S.; Lanvers-Kaminsky, C.; Jurgens, H.; Lamprecht-Dinnesen, A. Sequence variations of mitochondrial DNA and individual sensitivity to the ototoxic effect of cisplatin. Anticancer Res. 2003, 23 (2B), 1249–1255. [PUBMED], [INFOTRIEVE], [CSA]
- Kruppa, B.; Dieroff, H G.; Ising, H. Sensorineural hearing loss in children starting school. Results of a representative hearing screening study. HNO 1995, 43 (1), 31–34. [PUBMED], [INFOTRIEVE], [CSA]
- Niskar, A S.; Kieszak, S M.; Holmes, A.; Esteban, E.; Rubin, C.; Brody, D J. Prevalence of hearing loss among children 6 to 19 years of age: the Third National Health and Nutrition Examination Survey. JAMA 1998, 279 (14), 1071–1075. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pasic, T R.; Dobie, R A. Cis-platinum ototoxicity in children. Laryngoscope 1991, 101 (9), 985–991. [PUBMED], [INFOTRIEVE]
- McHaney, V A.; Thibadoux, G.; Hayes, F A.; Green, A A. Hearing loss in children receiving cisplatin chemotherapy. J. Pediatr. 1983, 102 (2), 314–317. [PUBMED], [INFOTRIEVE]
- Weatherly, R A.; Owens, J J.; Catlin, F I.; Mahoney, D H. Cis-platinum ototoxicity in children. Laryngoscope 1991, 101 (9), 917–924. [PUBMED], [INFOTRIEVE]
- Skinner, R.; Pearson, A D.; Amineddine, H A.; Mathias, D B.; Craft, A W. Ototoxicity of cisplatinum in children and adolescents. Br. J. Cancer 1990, 61 (6), 927–931. [PUBMED], [INFOTRIEVE]
- Hartmann, S.; Schäper, E.; Lamprecht-Dinnesen, A.; Boos, J. Ototoxizität von Cisplatin im Kindesalter. Otorhinolaryngol Nova 1995, 5, 222–230.
- Kretschmar, C S.; Warren, M P.; Lavally, B L.; Dyer, S.; Tarbell, N J. Ototoxicity of preradiation cisplatin for children with central nervous system tumors. J. Clin. Oncol. 1990, 8 (7), 1191–1198. [PUBMED], [INFOTRIEVE]
- Waters, G S.; Ahmad, M.; Katsarkas, A.; Stanimir, G.; McKay, J. Ototoxicity due to cis-diamminedichloroplatinum in the treatment of ovarian cancer: influence of dosage and schedule of administration. Ear Hear. 1991, 12 (2), 91–102. [PUBMED], [INFOTRIEVE]
- Fuchs, N.; Bielack, S S.; Epler, D.; Bieling, P.; Delling, G.; Korholz, D.; Graf, N.; Heise, U.; Jurgens, H.; Kotz, R.; Salzer, K M.; Weinel, P.; Werner, M.; Winkler, K. Long-term results of the co-operative German–Austrian–Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann. Oncol. 1998, 9 (8), 893–899. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Riggs, L C.; Brummett, R E.; Guitjens, S K.; Matz, G J. Ototoxicity resulting from combined administration of cisplatin and gentamicin. Laryngoscope 1996, 106 (4), 401–406. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schweitzer, V G.; Hawkins, J E.; Lilly, D J.; Litterst, C J.; Abrams, G.; Davis, J A.; Christy, M. Ototoxic and nephrotoxic effects of combined treatment with cis-diamminedichloroplatinum and kanamycin in the guinea pig. Otolaryngol. Head Neck Surg. 1984, 92 (1), 38–49. [PUBMED], [INFOTRIEVE]
- Klis, S F.; O'Leary, S J.; Hamers, F P.; De Groot, J C.; Smoorenburg, G F. Reversible cisplatin ototoxicity in the albino guinea pig. Neuroreport 2000, 11 (3), 623–626. [PUBMED], [INFOTRIEVE], [CSA]
- O'Leary, S J.; Klis, S F. Recovery of hearing following cisplatin ototoxicity in the guinea pig. Anticancer Res. 2002, 22 (3), 1525–1528. [PUBMED], [INFOTRIEVE], [CSA]
- Aguilar-Markulis, N V.; Beckley, S.; Priore, R.; Mettlin, C. Auditory toxicity effects of long-term cis-dichlorodiammineplatinum II therapy in genitourinary cancer patients. J. Surg. Oncol. 1981, 16 (2), 111–123. [PUBMED], [INFOTRIEVE]
- Laurell, G.; Jungnelius, U. High-dose cisplatin treatment: hearing loss and plasma concentrations. Laryngoscope 1990, 100 (7), 724–734. [PUBMED], [INFOTRIEVE]